RayzeBio, Inc. (RYZB)

NASDAQ: RYZB · IEX Real-Time Price · USD

22.37

-0.23 (-1.02%)

Nov 28, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Selling, General & Admin	10.94	5.5
Research & Development	61.18	33.88
Operating Expenses	72.12	39.38
Operating Income	-72.12	-39.38
Other Expense / Income	-3.52	-9.94
Pretax Income	-68.6	-29.44
Net Income	-68.6	-29.44
Preferred Dividends	4.55	27.14
Net Income Common	-73.15	-56.58
Shares Outstanding (Basic)	4	3
Shares Outstanding (Diluted)	4	3
Shares Change	36.66%	-
EPS (Basic)	-19.90	-21.03
EPS (Diluted)	-19.90	-21.03
Free Cash Flow	-60.78	-36.72
Free Cash Flow Per Share	-16.53	-13.65
EBITDA	-67.07	-28.99
Depreciation & Amortization	1.53	0.46
EBIT	-68.6	-29.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).